Baxter International is a venture capital firm in Illinois that focuses on saving and sustaining lives and elevating patient care. Founded 1931 in Deerfield, Illinois, United States, it invests in seed, series B, series C, debt financing and other venture rounds. Its portfolio companies include Visikol, Peripal, GroundLevel Insights Inc., and Vivet Therapeutics. As of March 2020, Baxter International has made eight investments. Their most recent investment was on May 6, 2014, when Naurex raised $25M. Baxter International has had two exits, the most notable of which include Ocular Therapeutix and Naurex.
Timeline
Products
Acquisitions
Invested in
Patents
Funding Rounds Participated In
Further reading
Baxter launches stem cell trial for chronic heart condition - MassDevice
MassDevice Staff
Web
Documentaries, videos and podcasts
Baxter Celebrates 10 Years of Innovative Anesthesiologist Scholarship Program
December 20, 2018
Join our North Cove Team -- This is where your work matters.
September 10, 2021